CureVac NV Cash Flow Quality Index

Latest as of September 2025: 0.11x

CureVac NV cash flow quality index. CureVac NV (5CV) has a Cash Flow Quality Index of 0.11x as of September 2025. Operating cash flow of €29.86 Million is below net income of €273.23 Million, suggesting accrual-heavy earnings not yet converted to cash. See CureVac NV (5CV) flexibility index to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

0.11x
Operating CF / Net Income

Operating Cash Flow

€29.86 Million
EUR

Net Income

€273.23 Million
EUR

Data as of

Sep 2025
Most recent filing

Cash Flow Quality Index of CureVac NV (2024–2024)

Cash flow quality index of CureVac NV from 2024 to 2024. Historical Cash Flow Quality Index for CureVac NV across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore CureVac NV cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

CureVac NV Cash Flow Quality Index by Year (2024–2024)

CureVac NV cash flow quality index by year from 2024 to 2024. Year-by-year earnings quality comparison for CureVac NV. For the full cash flow conversion analysis, see 5CV operating cash flow.

Year Quality Index Operating CF (EUR) Net Income YoY Change
2024 0.63x €101.85 Million €162.19 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.